Goldman Sachs’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136M Buy
558,300
+461,300
+476% +$107M 0.02% 867
2025
Q4
$20.1M Sell
97,000
-42,200
-30% -$8.35M ﹤0.01% 2362
2025
Q3
$25.8M Sell
139,200
-25,600
-16% -$4.39M ﹤0.01% 2002
2025
Q2
$25.2M Sell
164,800
-544,400
-77% -$83.7M ﹤0.01% 1926
2025
Q1
$118M Buy
709,200
+644,100
+989% +$101M 0.02% 708
2024
Q4
$9.41M Buy
65,100
+7,000
+12% +$1.08M ﹤0.01% 2857
2024
Q3
$9.42M Sell
58,100
-24,500
-30% -$3.9M ﹤0.01% 2794
2024
Q2
$12.1M Sell
82,600
-196,400
-70% -$29.2M ﹤0.01% 2320
2024
Q1
$44.1M Sell
279,000
-156,200
-36% -$24.9M 0.01% 1251
2023
Q4
$68.2M Buy
435,200
+203,700
+88% +$31.2M 0.01% 976
2023
Q3
$36.1M Buy
231,500
+8,100
+4% +$1.34M 0.01% 1334
2023
Q2
$37M Sell
223,400
-81,500
-27% -$13.2M 0.01% 1323
2023
Q1
$47.3M Buy
304,900
+276,400
+970% +$44.6M 0.01% 1107
2022
Q4
$5.03M Buy
28,500
+16,500
+138% +$2.85M ﹤0.01% 3156
2022
Q3
$1.96M Buy
12,000
+700
+6% +$118K ﹤0.01% 3992
2022
Q2
$2.01M Sell
11,300
-125,800
-92% -$22.4M ﹤0.01% 4055
2022
Q1
$24.3M Sell
137,100
-47,500
-26% -$8.08M 0.01% 1902
2021
Q4
$31.6M Sell
184,600
-68,300
-27% -$11.2M 0.01% 1719
2021
Q3
$40.8M Sell
252,900
-18,300
-7% -$3.12M 0.01% 1439
2021
Q2
$44.7M Sell
271,200
-7,700
-3% -$1.27M 0.01% 1361
2021
Q1
$45.8M Sell
278,900
-59,800
-18% -$9.68M 0.01% 1233
2020
Q4
$53.3M Buy
338,700
+50,100
+17% +$7.39M 0.01% 1087
2020
Q3
$43M Sell
288,600
-42,200
-13% -$6.24M 0.01% 1119
2020
Q2
$46.5M Sell
330,800
-232,900
-41% -$33.9M 0.01% 1014
2020
Q1
$73.9M Buy
563,700
+84,800
+18% +$12M 0.03% 644
2019
Q4
$69.9M Buy
478,900
+38,500
+9% +$5.22M 0.02% 923
2019
Q3
$57M Buy
440,400
+13,100
+3% +$1.73M 0.02% 1028
2019
Q2
$59.5M Sell
427,300
-340,500
-44% -$47.1M 0.02% 1030
2019
Q1
$107M Buy
767,800
+275,600
+56% +$36.9M 0.03% 619
2018
Q4
$63.5M Buy
492,200
+276,100
+128% +$38.5M 0.02% 905
2018
Q3
$29.9M Sell
216,100
-34,400
-14% -$4.57M 0.01% 1613
2018
Q2
$30.4M Sell
250,500
-59,700
-19% -$7.45M 0.01% 1588
2018
Q1
$39.8M Sell
310,200
-17,900
-5% -$2.42M 0.01% 1349
2017
Q4
$45.8M Sell
328,100
-138,700
-30% -$19.3M 0.01% 1349
2017
Q3
$60.7M Sell
466,800
-97,000
-17% -$12.9M 0.01% 1144
2017
Q2
$74.6M Buy
563,800
+77,800
+16% +$9.92M 0.02% 979
2017
Q1
$60.5M Sell
486,000
-36,900
-7% -$4.41M 0.02% 1100
2016
Q4
$60.2M Buy
522,900
+70,100
+15% +$8.1M 0.02% 1122
2016
Q3
$53.5M Sell
452,800
-470,500
-51% -$57.1M 0.02% 1152
2016
Q2
$112M Sell
923,300
-4,451,600
-83% -$506M 0.04% 599
2016
Q1
$582M Sell
5,374,900
-774,000
-13% -$80.1M 0.19% 83
2015
Q4
$632M Sell
6,148,900
-393,100
-6% -$39.5M 0.2% 81
2015
Q3
$611M Buy
6,542,000
+4,998,600
+324% +$484M 0.21% 75
2015
Q2
$150M Buy
1,543,400
+1,061,700
+220% +$106M 0.05% 448
2015
Q1
$48.5M Sell
481,700
-249,400
-34% -$25.4M 0.02% 1123
2014
Q4
$76.5M Buy
731,100
+180,800
+33% +$19.1M 0.02% 825
2014
Q3
$58.7M Sell
550,300
-193,900
-26% -$20.1M 0.02% 959
2014
Q2
$77.9M Sell
744,200
-932,000
-56% -$94.2M 0.02% 813
2014
Q1
$165M Sell
1,676,200
-99,000
-6% -$9.18M 0.05% 393
2013
Q4
$163M Sell
1,775,200
-1,400,800
-44% -$129M 0.05% 422
2013
Q3
$275M Buy
3,176,000
+959,600
+43% +$86.1M 0.1% 196
2013
Q2
$190M Buy
+2,216,400
New +$188M 0.07% 294

Other funds holding JNJ

Goldman Sachs's JNJ Position: Q1 2026 in Review

Goldman Sachs increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $400M and bringing the position to 18,057,047 shares worth $4.41B. The position accounts for 0.51% of the portfolio, ranked #24.

Goldman Sachs first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Goldman Sachs held 18,057,047 shares of Johnson & Johnson worth $4.41B as of Q1 2026.
  • Goldman Sachs bought 1,716,975 Johnson & Johnson shares in Q1 2026, an estimated $400M.
  • Johnson & Johnson made up 0.51% of Goldman Sachs's portfolio in Q1 2026, its #24 holding.
  • Goldman Sachs first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.